AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Valneva's 15min chart sees KDJ Golden Cross, Bullish Marubozu trend.
ByAinvest
Friday, Oct 10, 2025 1:20 pm ET1min read
Valneva's 15-minute chart has triggered a significant technical indicator, the KDJ Golden Cross, accompanied by a bullish Marubozu at 10:10 on October 10th, 2025. This signals a shift in the momentum of the stock price towards the upside, with potential for further growth. The control of the market is now in the hands of buyers, and it is likely that bullish momentum will continue.
Valneva SE (NASDAQ: VALN), a biotechnology company specializing in vaccines, has revised its 2025 financial outlook due to the U.S. FDA's August decision to revoke the marketing authorization for its chikungunya vaccine Ixchiq over safety concerns. The company has now projected full-year sales to be €155M-€170M, down from the previously anticipated €170-€180M, and revenue to be €165M-€180M, down from the earlier forecast of €180M-€190M [1].In response to the regulatory setback, Valneva entered into a debt facility of up to $500M with funds managed by Pharmakon Advisors. The initial tranche of $215M will be used to pay off an existing debt facility with Deerfield Management Company and OrbiMed, while the remaining up to $285M can be drawn in the future for business development.
Despite the setback, Valneva remains optimistic about its pipeline. The phase 3 trial of its Lyme disease vaccine asset is on schedule, and partner Pfizer (PFE) is expected to submit a Biologics License Application to the FDA and a Marketing Authorization Application to the European Medicines Agency in 2026, assuming positive phase 3 data.
On a separate note, Valneva's stock price has shown a significant technical indicator, the KDJ Golden Cross, accompanied by a bullish Marubozu at 10:10 on October 10th, 2025. This signals a shift in the momentum of the stock price towards the upside, with potential for further growth. The control of the market is now in the hands of buyers, and it is likely that bullish momentum will continue .
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet